Aging and death-associated changes in serum albumin variability over the course of chronic hemodialysis treatment
Autor: | Hiromi Shimoyama, Akihisa Watanabe, Yuichi Nakazato, Riichi Kurane, Satoru Hirose |
---|---|
Rok vydání: | 2017 |
Předmět: |
Male
Aging Physiology 030232 urology & nephrology 030204 cardiovascular system & hematology Biochemistry 0302 clinical medicine Endocrinology Mathematical and Statistical Techniques Interquartile range Epidemiology Chronic Kidney Disease Medicine and Health Sciences Homeostasis Multidisciplinary biology Frailty Middle Aged Death Nephrology Physical Sciences Medicine Regression Analysis Female Statistics (Mathematics) Research Article medicine.medical_specialty Endocrine Disorders Coefficient of variation Science Serum albumin Linear Regression Analysis Research and Analysis Methods 03 medical and health sciences Renal Dialysis Diabetes mellitus Albumins Linear regression Medical Dialysis medicine Diabetes Mellitus Humans Chronic hemodialysis Statistical Methods Serum Albumin Demography Models Statistical business.industry Albumin Biology and Life Sciences Proteins medicine.disease Geriatrics Metabolic Disorders biology.protein business Physiological Processes Mathematics |
Zdroj: | PLoS ONE PLoS ONE, Vol 12, Iss 9, p e0185216 (2017) |
ISSN: | 1932-6203 |
Popis: | BackgroundSeveral epidemiological studies have demonstrated associations between variability in a number of biological parameters and adverse outcomes. As the variability may reflect impaired homeostatic regulation, we assessed albumin variability over time in chronic hemodialysis (HD) patients.MethodsData from 1346 subjects who received chronic HD treatment from May 2001 to February 2015 were analyzed according to three phases of HD treatment: post-HD initiation, during maintenance HD treatment, and before death. The serum albumin values were grouped according to the time interval from HD initiation or death, and the yearly trends for both the albumin levels and the intra-individual albumin variability (quantified by the residual coefficient of variation: Alb-rCV) were examined. The HD initiation and death-associated changes were also analyzed using generalized additive mixed models. Furthermore, the long-term trend throughout the maintenance treatment period was evaluated separately using linear regression models.ResultsAlbumin levels and variability showed distinctive changes during each of the 3 periods. After HD initiation, albumin variability decreased and reached a nadir within a year. During the subsequent maintenance treatment period (interquartile range = 5.2-11.0 years), the log Alb-rCV showed a significant upward trend (mean slope: 0.011 ± 0.035 /year), and its overall mean was -1.49 ± 0.08 (equivalent to an Alb-rCV of 3.22%). During the 1-2 years before death, this upward trend clearly accelerated, and the mean log Alb-rCV in the last year of life was -1.36 ± 0.17. The albumin levels and variability were negatively correlated with each other and exhibited exactly opposite movements throughout the course of chronic HD treatment. Different from the albumin levels, albumin variability was not dependent on chronological age but was independently associated with an individual's aging and death process.ConclusionThe observed upward trend in albumin variability seems to be consistent with a presumed aging-related decline in homeostatic capacity. |
Databáze: | OpenAIRE |
Externí odkaz: |